This page lists the SEC filings reported by Meyer Thomas.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2024-03-13 | Meyer Thomas | Altamira Therapeutics Ltd. | 22,297 | 1.2% | EDGAR |
| SC 13D/A | 2023-04-27 | Meyer Thomas | Altamira Therapeutics Ltd. | 88,603 | 1.3% | EDGAR |
| SC 13D/A | 2023-01-18 | Meyer Thomas | Altamira Therapeutics Ltd. | 84,106 | 6.3% | EDGAR |
| SC 13D/A | 2022-09-13 | Meyer Thomas | Altamira Therapeutics Ltd. | 1,677,152 | 8.0% | EDGAR |
| SC 13D/A | 2022-05-13 | Meyer Thomas | Altamira Therapeutics Ltd. | 1,163,639 | 7.4% | EDGAR |
| SC 13D/A | 2021-05-21 | Meyer Thomas | Auris Medical Holding Ltd. | 817,263 | 6.3% | EDGAR |
| SC 13D/A | 2020-12-07 | Meyer Thomas | Auris Medical Holding Ltd. | 660,525 | 5.7% | EDGAR |
| SC 13D/A | 2020-10-06 | Meyer Thomas | Auris Medical Holding Ltd. | 660,525 | 9.2% | EDGAR |
| SC 13D/A | 2020-08-20 | Meyer Thomas | Auris Medical Holding Ltd. | 532,912 | 8.0% | EDGAR |
| SC 13D/A | 2019-08-12 | Meyer Thomas | Auris Medical Holding Ltd. | 529,573 | 15.4% | EDGAR |
| SC 13D/A | 2019-06-13 | Meyer Thomas | Auris Medical Holding Ltd. | 489,573 | 14.4% | EDGAR |
| SC 13D/A | 2018-11-21 | Meyer Thomas | Auris Medical Holding AG | 9,165,947 | 27.1% | EDGAR |
| SC 13D/A | 2018-07-23 | Meyer Thomas | Auris Medical Holding AG | 5,869,083 | 24.4% | EDGAR |
| SC 13D | 2018-04-03 | Meyer Thomas | Auris Medical Holding AG | 775,868 | 12.6% | EDGAR |
| SC 13D/A | 2017-02-21 | Meyer Thomas | Auris Medical Holding AG | 7,642,500 | 17.2% | EDGAR |
| SC 13D/A | 2016-06-01 | Meyer Thomas | Auris Medical Holding AG | 6,792,500 | 19.8% | EDGAR |
| SC 13D | 2014-08-14 | Meyer Thomas | Auris Medical Holding AG | 6,742,250 | 23.9% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.